1. Home
  2. MREO vs NWPX Comparison

MREO vs NWPX Comparison

Compare MREO & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • NWPX
  • Stock Information
  • Founded
  • MREO 2015
  • NWPX 1966
  • Country
  • MREO United Kingdom
  • NWPX United States
  • Employees
  • MREO N/A
  • NWPX N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • MREO Health Care
  • NWPX Industrials
  • Exchange
  • MREO Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • MREO 281.6M
  • NWPX 420.8M
  • IPO Year
  • MREO N/A
  • NWPX 1995
  • Fundamental
  • Price
  • MREO $1.73
  • NWPX $51.82
  • Analyst Decision
  • MREO Strong Buy
  • NWPX Hold
  • Analyst Count
  • MREO 5
  • NWPX 1
  • Target Price
  • MREO $7.40
  • NWPX $55.00
  • AVG Volume (30 Days)
  • MREO 910.9K
  • NWPX 51.4K
  • Earning Date
  • MREO 11-11-2025
  • NWPX 10-29-2025
  • Dividend Yield
  • MREO N/A
  • NWPX N/A
  • EPS Growth
  • MREO N/A
  • NWPX 32.83
  • EPS
  • MREO N/A
  • NWPX 3.32
  • Revenue
  • MREO $500,000.00
  • NWPX $499,125,000.00
  • Revenue This Year
  • MREO N/A
  • NWPX $4.00
  • Revenue Next Year
  • MREO $55.50
  • NWPX $3.96
  • P/E Ratio
  • MREO N/A
  • NWPX $15.72
  • Revenue Growth
  • MREO N/A
  • NWPX 5.83
  • 52 Week Low
  • MREO $1.47
  • NWPX $36.97
  • 52 Week High
  • MREO $4.72
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • MREO 45.94
  • NWPX 55.17
  • Support Level
  • MREO $1.68
  • NWPX $51.14
  • Resistance Level
  • MREO $1.88
  • NWPX $53.02
  • Average True Range (ATR)
  • MREO 0.08
  • NWPX 1.52
  • MACD
  • MREO 0.01
  • NWPX -0.39
  • Stochastic Oscillator
  • MREO 31.82
  • NWPX 39.00

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

Share on Social Networks: